(Q42807795)

English

Bis(N,N-dimethylhydroxamido)hydroxooxovanadate inhibition of protein tyrosine phosphatase activity in intact cells: comparison with vanadate

scientific article published on December 1999

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Bis(N,N-dimethylhydroxamido)hydroxooxovanadate inhibition of protein tyrosine phosphatase activity in intact cells: comparison with vanadate (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

author name string

Cuncic C

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Desmarais S

2

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Detich N

3

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Tracey AS

4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Gresser MJ

5

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Ramachandran C

6

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

1859-1867

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Protein tyrosine phosphatases: mechanisms of catalysis and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Protein tyrosine phosphatases in signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Potent Inhibition of Insulin Receptor Dephosphorylation by a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F2Pmp

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Affinity selection from peptide libraries to determine substrate specificity of protein tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Activation of permeabilized HL60 cells by vanadate. Evidence for divergent signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Effect of orthovanadate on tyrosine phosphorylation of P120 GTPase-activating protein in rat liver macrophages (Kupffer cells)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

New insights into the role and mechanism of glycogen synthase activation by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Oral vanadate decreases muscle insulin resistance in obese fa/fa rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Vanadium and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Intracluster restriction of Fc receptor gamma-chain tyrosine phosphorylation subverted by a protein-tyrosine phosphatase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900284-1

7 January 2021

Identifiers

10.1016/S0006-2952(99)00284-1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42807795&oldid=1970886925"